Despite sliding in a hair under analyst estimates, Monster Beverage
Of course, Monster hasn't had to digest a major bottling subsidiary, nor did it gain any Dr Pepper Snapple
Breaking down the numbers
Monster has its best quarters in the summer, but its latest results are quite a bit higher than 2009's peak sales:
Sources: Morningstar and Monster Beverage earnings release.
The company continues to expand its product line and broaden its European push, laying siege to the stronghold of privately held Red Bull. One of its newer products is Monster Rehab, an Arnold Palmer (that means iced tea and lemonade) concoction that's touted as one of its current best sellers. The branding and caffeinated nature of the drink sets it apart from other iced teas made by Coke, Snapple, and PepsiCo's
Dr Pepper Snapple's been kind of woebegone over the last few years, so let's compare Coke and Pepsi's growth rates to Monster, whose $1.7 billion in revenue is an 88% improvement over their 2007 annual total, handily beating both Coke and Pepsi, both of which have far more diversified businesses. Granted, Monster doesn't offer a dividend, and its earnings multiple is twice either Coke's or Pepsi's. But much of the Big Two's growth has been from major overseas expansions, a process that Monster's barely begun.
Do you think Monster's got enough energy left in the tank to keep its pace through 2012? Analysts expect a brisk growth rate going forward. That ought to keep Monster stockholders like its consumers -- a little revved up.
Add Monster Beverage to your Watchlist to keep track of all the news and opinions that bubble up. Looking for another huge growth opportunity? Take a look at The Motley Fool's brand-new free report on one amazing multibagger that's transforming its industry. Our subscribers have reaped big rewards from this company's success, but it's just getting started. Find out more -- claim your free copy now.